Advertisement

Is there disease progression in patients who are hepatitis C virus antibody–positive and hepatitis C virus RNA–seronegative?

Authors


  • See Article on Page 1737.

  • Potential conflict of interest: Dr. Wiesner received grants from Roche and Novartis.

No abstract is available for this article.

Ancillary